Surgery Websites

Discovering Treatments & Cures Through Innovative Translational Research

The Warren laboratory in surgical oncology is conducting research aimed at identifying lesions that lead to the development and spread of cancer.

.

Recent Publications

MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.

Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.

Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth.

Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.

The Sall2 transcription factor is a novel p75NTR binding protein that promotes the development and function of neurons.

Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity.

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.

View all Publications »

News & Events

Read all news »

Site Directory